Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro) Meeting Abstract
| Authors: | Hui, R.; Gandhi, L.; Costa, E. C.; Felip, E.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Leighl, N. B.; Aggarwal, C.; Horn, L.; Patnaik, A.; Middleton, G. W.; Gubens, M. A.; Hellmann, M. D.; Soria, J. C.; Ramalingam, S. S.; Lubiniecki, G. M.; Zhang, J.; Piperdi, B.; Garon, E. B. |
| Abstract Title: | Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 462s |
| Language: | English |
| ACCESSION: | WOS:000404711506174 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9026 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9026 -- Source: Wos |
